Neuspera Medical Revenue and Competitors

Location

$111.9M

Total Funding

Estimated Revenue & Valuation

  • Neuspera Medical's estimated annual revenue is currently $6.1M per year.(i)
  • Neuspera Medical's estimated revenue per employee is $125,500
  • Neuspera Medical's total funding is $111.9M.

Employee Data

  • Neuspera Medical has 49 Employees.(i)
  • Neuspera Medical grew their employee count by -11% last year.

Neuspera Medical's People

NameTitleEmail/Phone
1
Founder, Chief Technology OfficerReveal Email/Phone
2
CEOReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
VP, Clinical and Regulatory AffairsReveal Email/Phone
5
SVP, Clinical Research and Regulatory AffairsReveal Email/Phone
6
VP Market Development and CommercializationReveal Email/Phone
7
Director, RF EngineeringReveal Email/Phone
8
Chief Medical OfficerReveal Email/Phone
9
Director Clinical ResearchReveal Email/Phone
10
Chief Operating OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Neuspera Medical?

Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neuspera’s minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.

keywords:N/A

$111.9M

Total Funding

49

Number of Employees

$6.1M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Neuspera Medical News

2021-07-21 - Neuspera Medical Closes $65M Series C Equity Financing

Neuspera Medical Inc., a San Jose, Calif.-based clinical stage, private venture capital backed neuromodulation company, closed a $65m series C equity financing. The round was co-led by Vertex Ventures HC and Treo Ventures with participation from returning Series A and Series B investors Action ...

2021-07-20 - Neuspera Medical scores $65M for nerve-stimulating implant to treat overactive bladder

Neuspera Medical’s miniaturized neuromodulation device may take up mere millimeters of space, but it’s making an outsized impact on the field of medical technology. RELATED: Bioelectronics startup Neuspera nets $26M in two-tranche series B The bulk of the financing will be funneled toward the ...

2021-07-20 - Neuspera Medical Announces Close of a $65M Series C Equity Financing

SAN JOSE, Calif., July 20, 2021 /PRNewswire/ -- Neuspera Medical Inc., a clinical stage, private venture capital backed neuromodulation company, today announced the closing of the company's $65 million series C equity financing. The Series C round was co-led by Vertex Ventures HC and Treo Vent ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.7M49N/AN/A
#2
$7.6M494%$45M
#3
$5.7M49N/AN/A
#4
$10.6M499%N/A
#5
$8.8M497%N/A